Responsible for resistance to chemotherapy-induced apoptosis, C-FLIP is overexpressed in several cancers, such as breast cancer, glioblastoma, and leukemia; however, its levels in CSCs are much higher than in normal cancer cells [128,129], inducing resistance to TRAIL-induced apoptosis. Here, CFLAR is linked to breast cancer.